Choosing the best practice: Evidence to support fluoroquinolone drops for acute otitis media through tympanostomy tubes [18]

Pediatrics

Volumn 120, Issue 1, 2007, Pages 245-247

  Dohar, Joseph ^a   Giles, William ^b   Roland, Peter ^c   Bikhazi, Nadim ^d   Carroll, Sean ^e   Moe, Roderick ^f   Reese, Bradley ^g   Dupre, Sheryl ^h   Wall, Michael ^h   Stroman, David ^h   McLean, Celeste ^h   Crenshaw, Krista ^h   Younis, Ramzi ⁱ   Poole, Michael ^e  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b CENTA Medical Group   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d Ogden Clinic   (United States)

^e ENT Specialists of NW Pennsylvania ^*

^f Pediatric ENT Institute of South Texas   (United States)

^g Florida Otolaryngology Group   (United States)

^h ALCON RESEARCH LTD   (United States)

ⁱ UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CIPROFLOXACIN; CIPROFLOXACIN PLUS DEXAMETHASONE; DEXAMETHASONE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; STEROID; UNCLASSIFIED DRUG;

ACUTE OTITIS MEDIA; ANTIBIOTIC RESISTANCE; DRUG EFFICACY; DRUG SAFETY; FINANCIAL MANAGEMENT; HUMAN; LETTER; MEDICAL PRACTICE; OTORRHEA; PATHOGENESIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STREPTOCOCCUS PNEUMONIAE; TREATMENT PLANNING; TYMPANOSTOMY TUBE;

ACUTE DISEASE; ADMINISTRATION, TOPICAL; CHILD, PRESCHOOL; FLUOROQUINOLONES; HUMANS; INFANT; MIDDLE EAR VENTILATION; OTITIS MEDIA WITH EFFUSION;

EID: 34447118730     PISSN: 00314005     EISSN: 02105721     Source Type: Journal    
DOI: 10.1542/peds.2007-1246     Document Type: Letter

References (9)

1. Isaacson G. Why don't those ear drops work for my patients? Pediatrics. 2006;118:1252-1253
2. Dohar J, Giles W, Roland P, et al. Topical ciprofloxacin/dexamethasone is superior to oral amoxicillin/clavulanic acid in acute otitis media with otorrhea through tympanostomy tubes. Pediatrics. 2006;118(3). Available at: www.pediatrics.org/cgi/content/full/118/3/e561
3. Centers for Disease Control and Prevention. CDC get smart. Available at: www.cdc.gov/drugresistance/community. Accessed May 10, 2007
4. Dohar JE, Kenna MA, Wadowsky RM. In vitro susceptibility of aural isolates of Pseudomonas aeruginosa to commonly used ototopical antibiotics. Am J Otol. 1996;17:207-209
5. Rosenfeld R, Isaacson G. Tympanostomy tube care and consequences. In: Rosenfeld RM, Bluestone CD, eds. Evidence-Based Otitis Media. Hamilton, Ontario Canada: BC Decker; 1999
6. Roland PS, Parry DA, Stroman DW. Microbiology of acute otitis media with tympanostomy tubes. Otolaryngol Head Neck Surg. 2005;133:585-595
7. Eskola J, Kilpi T, Palmu A; Finnish Otitis Media Study Group. Efficacy of pneumococcal conjugate vaccine against acute otitis media. N Engl J Med. 2001;344:403-409
8. Ohyama M, Furuta S, Ueno K, et al. Ofloxacin otic solution in patients with otitis media: an analysis of drug concentrations. Arch Otolaryngol Head Neck Surg. 1999;125:337-340
9. Ruohola A, Heikkinen T, Meurman O, Puhakka T, Lindblad N, Ruuskanen O. Antibiotic treatment of acute otorrhea through tympanostomy tube: randomized double-blind placebo-controlled study with daily follow-up. Pediatrics. 2003;111:1061-1067